10-K: NexPoint Capital, Inc. Reports Annual Results for Fiscal Year Ended December 31, 2024

NexPoint Capital, Inc. releases its 10-K filing, detailing investment activities and financial performance for the year ended December 31, 2024, highlighting a portfolio of middle-market healthcare and other sector investments.

Summary

• NexPoint Capital, Inc., a BDC, has released its 10-K filing for the fiscal year ended December 31, 2024.
• The company's investment objective is to generate current income and capital appreciation through investments in middle-market companies.
• As of December 31, 2024, the investment portfolio's fair value was $44.5 million, spread across 26 positions.
• The portfolio includes first lien senior secured loans (14.2%), third lien senior secured loans (1.4%), corporate bonds (0.5%), common stocks (37.7%), preferred stocks (25.8%), and LLC interests (20.4%).
• The debt investments in the portfolio have a weighted average cost price of 90.29% and an estimated gross annual portfolio yield of 2.45%.
• The company reported a net investment income of $607,948, or $0.07 per share, for the year ended December 31, 2024.
• Net realized losses were $(494,867), and the net change in unrealized appreciation on investments was $1,883,903.
• The net increase in net assets resulting from operations was $1,996,984, or $0.22 per share.
• Operating expenses included $945,241 in base management fees and $186,249 in administrative services expenses paid to the Adviser.
• The Adviser is contractually obligated to waive fees and, if necessary, pay or reimburse certain other expenses to limit ordinary Other Expenses to 1.0% of the quarter-end value of the Companys gross assets through April 30, 2025.
• As of December 31, 2024, the cumulative total of fees waived by the Adviser under the Expense Limitation Agreement which are recoupable is $1,274,344.
• Liberty CLO Holdco Ltd. controls 2,549,002 shares of the company, representing 29.31% of the outstanding common stock, with a net amount of approximately $14.2 million.
• The company intends to offer to repurchase shares of common stock at a price equal to 90% of the offering price in effect on each date of repurchase.
• On February 21, 2025, the Company announced a tender offer for up to 2.5% of its outstanding common stock.
• The tender offer expired on March 24, 2025, and 149,884.924 shares, or 1.71% were repurchased.

Sentiment

Score: 5

Explanation: The document presents a mixed sentiment. While the company maintains a substantial asset base and has a diversified portfolio, the decrease in net investment income and net realized losses raise concerns. The continued support from the Adviser through fee waivers is a positive, but the overall financial performance suggests a neutral to slightly negative outlook.

Positives

• The company's net assets remain substantial at $45,276,270.
• The Adviser is contractually obligated to waive fees and, if necessary, pay or reimburse certain other expenses to limit ordinary Other Expenses to 1.0% of the quarter-end value of the Companys gross assets through April 30, 2025.
• The company has a diversified portfolio across various asset classes and industries.

Negatives

• The company experienced net realized losses of $(494,867) for the year ended December 31, 2024.
• The company made $2,603,950 of distributions in excess of net investment income.
• The company's net investment income decreased from $1,666,934 in 2023 to $607,948 in 2024.

Risks

• The company's investments in middle-market companies are subject to various risks, including limited financial resources and dependence on key management.
• The company's investments in healthcare companies are subject to risks including competition, extensive government regulation and commercial difficulties.
• The company's investments in CLOs are subject to risks including less transparency and the risk of leverage.
• The company's investments in foreign securities are subject to risks including changes in exchange control regulations, political and social instability, and less liquid markets.
• The company's investments in illiquid securities are subject to the risk that the company may not be able to sell such investments if the need arises.
• The company's use of leverage is subject to the risk that the company's net assets will tend to increase or decrease at a greater rate than if borrowed funds are not used.
• The company's reliance on the Adviser is subject to the risk that the Adviser may not be able to manage the company's investments effectively.
• The company's dependence on key personnel of the Adviser and its affiliates is subject to the risk that the company may not be able to grow its investment portfolio if these individuals do not maintain their existing relationships or develop new relationships with other sources of investment opportunities.
• The company's status as a BDC and RIC is subject to the risk that the company may not be able to maintain its status as a BDC and RIC, which would reduce its operating flexibility and subject it to corporate-level income tax.

Future Outlook

The company intends to continue to generate high current income and long-term capital appreciation through investments in middle-market companies, syndicated floating rate debt, and CLOs.

Industry Context

The announcement reflects the ongoing investment activities within the BDC sector, particularly focusing on middle-market companies and healthcare, aligning with trends of seeking high current income and capital appreciation in specialized sectors.

Comparison to Industry Standards

• Given the focus on middle-market lending, NexPoint Capital's activities can be compared to other BDCs such as Ares Capital Corporation (ARCC) and Main Street Capital (MAIN), although their specific investment strategies and portfolio compositions may differ.
• ARCC, for example, also focuses on middle-market lending but has a significantly larger asset base and broader investment scope.
• MAIN, known for its efficient operations and focus on lower middle market companies, provides a different risk-return profile.
• The reported portfolio yield of 2.45% is relatively low compared to some peers, which may reflect a more conservative investment approach or different asset mix.
• For instance, some BDCs targeting higher yields may invest in riskier assets or employ greater leverage, impacting their overall risk profile.
• The level of affiliated investments, representing 20.5% of net assets, is a notable aspect that requires careful monitoring for potential conflicts of interest, a common concern in externally managed BDCs.
• This level of related-party transactions is higher than some industry peers, necessitating robust corporate governance and independent oversight.
• The expense ratio, influenced by the Adviser's fee waivers, is a key factor in assessing the efficiency of the BDC's operations.
• A lower expense ratio, achieved through fee waivers, can enhance returns to shareholders, making it a competitive advantage compared to BDCs with higher operating costs.

Related Party Transactions

• The company has entered into an Investment Advisory Agreement with the Adviser, who is controlled by James Dondero.
• The company reimburses the Adviser for expenses under the Administration Agreement.
• The dealer manager, NexPoint Securities, Inc., is an affiliate of the Adviser.
• Liberty CLO Holdco Ltd. controls 2,549,002 shares of the company, representing 29.31% of the outstanding common stock, with a net amount of approximately $14.2 million.
• The Adviser has committed to voluntarily reimburse the Company for certain unrealized losses on investments.

Stakeholder Impact

• Shareholders may experience fluctuations in the value of their investments due to market risks and the company's investment strategies.
• The company's ability to make distributions to shareholders is dependent on its financial performance and compliance with regulatory requirements.
• The company's relationships with affiliated parties may create potential conflicts of interest that could impact shareholder value.

Next Steps

• The company intends to offer to repurchase shares of common stock at a price equal to 90% of the offering price in effect on each date of repurchase.
• The Board may amend, suspend or terminate the share repurchase program at any time, upon 30 days notice.

Key Dates

Keywords

BDC, middle-market, healthcare, investments, senior secured loans, corporate bonds, LLC interests, preferred stock, CLOs, financials